PSCHvsARKGETF Comparison
VS
Invesco S&P SmallCap Health Care ETF (PSCH) belongs to the US Health Care segment. ARK Genomic Revolution ETF (ARKG) is part of the BioTech & Genomics segment. Both ETFs have the same top 3 sector exposures: and Health Care. PSCH is less expensive with a Total Expense Ratio (TER) of 0.29%, versus 0.75% for ARKG. PSCH is up 1.6% year-to-date (YTD) with -$19M in YTD flows. ARKG performs better with 2.44% YTD performance, and -$37M in YTD flows. Run a side-by-side ETF comparison of PSCH and ARKG below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
PSCH vs ARKG performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 04/28/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | PSCH ARKG | +14.25%+19.74% | +0.97%-7.79% | +1.60%+2.44% | +8.95%+33.74% | +1.45%+3.79% | -29.04%-67.31% |
| Flows | PSCH ARKG | -$4M-$22M | -$18M-$94M | -$19M-$37M | -$33M-$81M | -$154M-$609M | -$237M-$3.04B |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | PSCH ARKG | +23.35%+42.80% | +20.91%+41.55% | +21.73%+42.57% | +22.88%+45.35% |
| Max drawdown | PSCH ARKG | -12.32%-23.56% | -15.36%-27.52% | -22.80%-51.98% | -47.23%-80.16% |
| Max drawdown duration | PSCH ARKG | 81d90d | 127d95d | 433d1013d | 1766d1763d |
Trading data
PSCH | ARKG | |
Last sale 4/29/2026 at 1:30 PM | $43.80 | $28.53 |
| Previous close 04/28/2026 | $44.77 | $29.58 |
| Consolidated volume 04/28/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of March 31, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
ARKG
is actively managed and doesn’t replicate an indexPSCH | ARKG | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 4/29/2026 at 1:30 PM
Live
Closed
PSCH | ARKG | |
|---|---|---|
| Last price | $43.80 | $28.53 |
| 1D performance | -2.16% | -3.57% |
| AuM | $129.45 M | $1.16 B |
| E/R | 0.29% | 0.75% |
Characteristics
PSCH | ARKG | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | Invesco | Ark Investment |
| Benchmark | S&P SmallCap 600 Capped Health Care Index | - |
| N° of holdings | 71 | 27 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | April 7, 2010 | April 2, 2019 |
| ESG | No | No |
Advertisement
Exposure
Countries
PSCH
USA
96.2%
Other
3.8%
ARKG
USA
70.4%
Switzerland
9.23%
Other
20.37%
Sectors
PSCH
Health Care
90.59%
Other
9.41%
ARKG
Health Care
78.38%
Other
21.62%
Advertisement
Diversification
PSCH
Total weight of top 15 holdings out of 15
44.68%
ARKG
Total weight of top 15 holdings out of 15
62.5%
Top 15 holdings
Data as of March 31, 2026
PSCH
MOLINA HLTHCRE
4.25%
KRYSTAL BIOTECH INC
3.90%
GLAUKOS
3.65%
PROTAGONIST THERAPEUTICS INC
3.58%
US10950A1060
3.45%
PTC THERAPEUTI/D
3.27%
TELEFLEX
3.16%
ALKERMES
2.99%
TG THERAPEUTICS
2.66%
MERIT MEDICAL SYSTEMS
2.51%
RADNET
2.41%
LIGAND PHARMACEUTICALS
2.37%
US45579U1097
2.23%
CORCEPT THERAPEUTICS
2.17%
TRANSMEDICS GROUP
2.08%
ARKG
CRISPR THERAPEUTICS
9.23%
10X GENOMICS INC
6.30%
BEAM THERAPEUTICS
4.86%
PERSONALIS INC
4.69%
NATERA
4.48%
ILLUMINA
4.45%
GUARDANT HEALTH INC
4.21%
INTELLIA THERAPEUTICS INC
3.58%
CAREDX INC/D
3.56%
RECURSION PHARMACEUTICALS
3.54%
ABSCI
3.27%
VERACYTE INC/D
2.98%
ADAPTIVE BIOTECHNOLOGIES
2.71%
NURIX THERAPEUTICS
2.45%
SEMA4 HOLDINGS CORP
2.19%
Frequently asked questions about PSCH and ARKG
How have the PSCH and ARKG ETFs performed in 2026?
As of April 28, 2026, PSCH is up 1.6% year-to-date (YTD), while ARKG has returned 2.44%. That puts ARKG better performer ahead so far this year.
Which ETF is attracting more investor money: PSCH or ARKG?
Year-to-date, the PSCH ETF saw -$19M in flows, compared to -$37M for ARKG.
Which ETF is more volatile: PSCH or ARKG?
Over the past year, PSCH had a volatility of 20.91%, while ARKG experienced 41.55%.
Which ETF is bigger: PSCH or ARKG?
As of April 28, 2026, PSCH holds $129.45 M in assets under management (AUM), while ARKG manages $1.16 B.
What sectors do the PSCH and ARKG ETFs invest in?
PSCH leans toward sectors like Health Care. Meanwhile, ARKG focuses on Health Care.
What are the top holdings of the PSCH ETF and ARKG ETF?
PSCH top holdings include MOLINA HLTHCRE, KRYSTAL BIOTECH INC and GLAUKOS. ARKG holds in its top three: CRISPR THERAPEUTICS, 10X GENOMICS INC and BEAM THERAPEUTICS.
Which ETF is more diversified: PSCH or ARKG?
PSCH holds 75 securities with 44.68% of its assets in the top 15. ARKG has 27 securities and a top 15 weight of 62.5%.
Advertisement
Latest news about PSCH & ARKG
Advertisement
